$12B Nestle-Pfizer Deal Could Impact Formula Market: Regulator
Australia's antitrust regulator voiced concern Friday over Swiss food giant Nestle SA's planned $11.9 billion acquisition of Pfizer Inc.'s infant nutrition business, saying the merger could diminish competition in the country's...To view the full article, register now.
Already a subscriber? Click here to view full article